00:22 , Apr 13, 2016 |  BC Extra  |  Financial News

Forbion closes third life sciences fund

Forbion Capital Partners closed its third life sciences fund, Forbion Capital Fund III, at EUR 183 million ($208.2 million). The fund's LPs include the European Investment Fund, Dutch Venture Initiative, KfW, Charles River Laboratories International...
08:00 , Jan 27, 2014 |  BC Week In Review  |  Company News

Autonomic Technologies management update

Autonomic Technologies Inc. , Redwood City, Calif.   Business: Neurology   Hired: Shashidhar Kori as CMO, formerly VP of clinical development and medical affairs at Allergan Inc.  ...
08:00 , Mar 5, 2012 |  BC Week In Review  |  Clinical News

ATI Neurostimulation System: Pivotal trial started

Autonomic Technologies said investigators began the single-blind, European pivotal Pathway M-1 trial to evaluate the company's ATI Neurostimulation System in at least 30 patients. The company expects a decision on CE Mark approval in Europe...